(Q33919321)

30 July 2017

1 reference

title

Long-term prevention of ischaemic stroke and stroke recurrence (English)

1 reference

30 July 2017

Ringelstein EB

1

1 reference

30 July 2017

Nabavi D

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

98

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

83-96

1 reference

Familial aggregation of stroke. The Framingham Study

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prospective study of endogenous tissue plasminogen activator and risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Five-year changes in population blood pressure and hypertension prevalence. Results from the MONICA Augsburg surveys 1984/85 and 1989/90.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

The Epidemiological Association between Blood Pressure and Stroke: Implications for Primary and Secondary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Incidence and risk factors for stroke in an occupational cohort: the PROCAM Study. Prospective Cardiovascular Muenster Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Double-blind randomised trial of modest salt restriction in older people.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Meta-analysis of relation between cigarette smoking and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Cigarette smoking and stroke in a cohort of U.S. male physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Diabetes and the risk of stroke. The Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Hyperinsulinism and cerebral microangiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Moderate alcohol consumption and stroke. The epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Risk factors for spontaneous intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Protective effect of fruits and vegetables on development of stroke in men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Primary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Physical activity and stroke in British middle aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Physical activity and stroke risk: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Physical activity and stroke incidence in women and men. The NHANES I Epidemiologic Follow-up Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Exercise and risk of stroke in male physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Natural history of asymptomatic extracranial arterial disease. Results of a long-term prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

The case against surgery for asymptomatic carotid stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Secular trends in the prevalence of atrial fibrillation: The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Cerebrovascular accident complicating acute myocardial infarction: Incidence, clinical significance, and short-long-term mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Mitral annular calcification and the risk of stroke in an elderly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

World distribution of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Determinants of early recurrence of cerebral infarction. The Stroke Data Bank

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Percutaneous transluminal angioplasty of the vertebral artery. A therapeutic alternative to operative reconstruction of proximal vertebral artery stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900230-9

7 January 2021

10.1016/S0049-3848(00)00230-9

Identifiers

DOI

1 reference

30 July 2017

1 reference